07/25/2026
BIG NEWS FOR PEPTIDE THERAPY
A major step forward for personalized medicine.
The Pharmacy Compounding Advisory Committee has voted to recommend adding these peptides to the approved list of ingredients for compounding:
✔️ BPC-157
✔️ KPV
✔️ TB-500
✔️ MOTS-c
✔️ Epitalon
✔️ Semax
While this is not yet the final FDA decision, it represents meaningful progress toward preserving access to personalized treatment options for patients and providers.
At Bloom, we’re committed to staying at the forefront of regenerative medicine and providing evidence-based wellness solutions while remaining fully compliant with all applicable regulations.
Have questions about peptide therapy or wondering if it’s right for you?
📩 Send us a DM or give us a call. We’re here to help.